Viewing Study NCT05608005


Ignite Creation Date: 2025-12-25 @ 3:27 AM
Ignite Modification Date: 2025-12-26 @ 2:08 AM
Study NCT ID: NCT05608005
Status: COMPLETED
Last Update Posted: 2025-09-24
First Post: 2022-10-20
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Study on Two Adjuvanted Dose Levels of Panblok H7+MF59 Compared for Immunogenicity and Safety With an Unadjuvanted Dose of Panblok H7 in Participants 18 Years of Age and Older
Sponsor: Sanofi Pasteur, a Sanofi Company
Organization: